SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Roche's signage at its office in France
Weight loss
Roche’s Obesity Pill Candidate Hit With Safety Concerns Despite Strong Efficacy Data
When doses were increased rapidly in a Phase I study, patients on Roche’s investigational oral GLP-1 receptor agonist experienced nausea, vomiting, constipation, diarrhea, as well as abdominal distension.
September 12, 2024
 · 
2 min read
 · 
Tristan Manalac
Drug Development
AI Promises: Funding Data Literacy and Reality First
In this episode, Lori and guests discuss practical approaches regarding artificial intelligence and investor and industry confidence in its current state.
September 12, 2024
 · 
1 min read
 · 
Lori Ellis
Downtown San Francisco
Job Trends
California Tops Biopharma Job Openings So Far in 2024, Per BioSpace Data
For the first eight months of 2024, California had the most job postings live on BioSpace—37.7% more than Massachusetts. Last year, Massachusetts ranked No.1 for the same time period.
September 12, 2024
 · 
4 min read
 · 
Angela Gabriel
Illustration where small sphere supports large sphere
Opinion
Opinion: A Small Pharma Mindset Can Reshape Big Pharma and Improve Patient Care
An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.
September 12, 2024
 · 
3 min read
 · 
Jill Marie Drury
The IQVIA and BioSpace logos appear on a blue background image with the title Embracing Agility: Critical for the role of QARA professional? and a "watch now" button
IN PARTNERSHIP WITH IQVIA
Webinar: Embracing Agility: Critical for the role of QARA professional?
Join our webinar to explore strategies, best practices, and the evolving landscape of QARA in today’s dynamic market.
September 11, 2024
 · 
1 min read
Facade of Novo Nordisk's office in Fremont, California
Weight Loss
Novo’s Obesity Pill Yields ‘Remarkable’ 13% Weight Loss, Investigators Say
On the heels of Terns’ positive Phase I results that analysts compared with Lilly’s and Pfizer’s weight loss pills in development, Novo Nordisk showcased more details about its own oral candidate.
September 11, 2024
 · 
2 min read
 · 
Annalee Armstrong
DNA chain and words. 3D rendering
Gene Therapy
Vertex, CRISPR’s Casgevy Highlights Complex Path to Gene Therapy Profitability
No patients have received Casgevy, CRISPR Therapeutics and Vertex Pharmeceuticals’ recently approved sickle cell gene therapy. Experts weigh in on the path to profit for the treatment and the therapeutic class in general.
September 11, 2024
 · 
7 min read
 · 
Annalee Armstrong
United States Capitol Building & dollar bills /
Pharmacy benefit managers
Can PBM Reform Lower Drug Prices?
Healthcare players are pointing fingers amid regulatory crackdowns on pharmacy benefit managers, but proposed reforms wouldn’t address a dearth of competition in the larger market.
September 11, 2024
 · 
5 min read
 · 
Keerthi Vedantam
illustration of hands reaching for a semaglutide injector over an image of the Earth
Policy
What Expanded CVD Medicare Coverage May Mean for Novo Nordisk’s Wegovy
A recent study estimated that Wegovy’s label expansion beyond obesity could push Medicare spending to $145 billion annually, but analysts remain dubious of the estimate.
September 11, 2024
 · 
6 min read
 · 
Nick Paul Taylor
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS